Dexcom announced today that it entered into a strategic partnership with Oura, maker of leading smart ring technology.

Abbott modified its original FreeStyle Libre 2 for the purpose of integration with automated insulin delivery systems. It ...

Medtronic announced today that it received FDA clearance for its new InPen insulin delivery system application.

Embecta announced today that it discontinued its insulin patch pump program and plans to initiate a restructuring plan.

Abbott announced today that it officially opened a new state-of-the-art manufacturing facility in Kilkenny, Ireland.

Beta Bionics announced today that it closed a Series E preferred stock financing round worth a total of $60 million.

Medtronic (NYSE:MDT) has plans to submit its MiniMed 780G for an expanded indication from the FDA for type 2 diabetes in the near future.

Embecta (Nasdaq:EMBC) announced today that it discontinued its insulin patch pump program and plans to initiate a restructuring plan. Shares of EMBC ticked up 4.3% to $14.41 apiece before hours after ...